Prostate Cancer Care Disparity Analysis Project (ProGAP)

StatusUnknown
PhaseNot specified
Started

Record status This record was last updated July 24, 2025 (before its estimated October 30, 2025 completion). Its status may not reflect the trial's current state.

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
  2. Trial status: Not Yet Recruiting to Recruitingv3 Show 4 more changesShow less
    • Primary completion date: Jan 15, 2025 to Oct 30, 2025
    • Start date changed from estimate of Nov 1, 2024 to Mar 10, 2025
    • Study sites: 0 to 1
    • Study completion date: Feb 15, 2025 to Oct 30, 2025
  3. Eligibility criteria shortened, about 10 wordsv2
  4. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This international cross-sectional study seeks to evaluate global disparities in prostate cancer management by conducting a thorough comparison of key elements across countries categorized as low-income, lower-middle-income, upper-middle-income, and high-income. The primary question it addresses is: Are the standards of care for prostate cancer uniformly applied across different geographic regions worldwide? To achieve this, we will recruit physicians specializing in the diagnosis and treatment of prostate cancer from a diverse array of countries within these income classifications. Participants will complete a 17-question online survey.
Trial Details
NCT Number NCT06612034
Lead Sponsor Ankara University
Conditions
(from sponsor)		 Prostate CA
Related terms Prostatic Neoplasms
Enrollment 400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov